Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about AZN

Recent news which mentions AZN

< Previous 1 2
...
18 19 20 21 22 23 24 25 26
...
32 33 Next >
Drug companies plan to raise prices on vital medicines to fund R&D, but they already spend more on shareholder returns
Tickers AZN BMY PFE SNY
Tags SNY FR:SAN UK:AZN
From MarketWatch
Will 2023 be the year that pharma M&A makes a comeback?
Tickers ALBO AMGN AMYT APLS
Tags CINC AMGN SPX
From MarketWatch
Could This New Drug Launch Be a Hit for Viatris?
Tickers AZN VTRS
Tags AZN VTRS Market News
From Motley Fool
AstraZeneca's New Asthma Treatment for Adults Gets Green Light from FDA
Tickers AZN AZNCF
Tags Large Cap AZN General
From Benzinga
Why Is CinCor (CINC) Stock Up 138% Today?
Tickers AZN BABA BBBY CINC
Tags CINC Market News NASDAQ:CINC,NASDAQ:AZN,NASDAQ:BBBY,NYSE:BABA,NASDAQ:TSLA
From InvestorPlace
Tesla's Delivery Wait Times Go Up, China Wants To Secure License For Generic Version Of Pfizer's Paxlovid, India-Made iPhone Exports Surpass $2.5B: Today's Top Stories
Tickers AAPL AZN CINC DE
Tags HNHPF Penny Stocks Large Cap
From Benzinga
AstraZeneca To Acquire CinCor Pharma To Strengthen Cardiorenal Pipeline
Tickers AZN AZNCF CINC
Tags Large Cap Movers General
From Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
Tickers ALBO AMYT APGN AZN
Tags Today's Market AZN BBBY
From InvestorPlace
European drugmakers including AstraZeneca pony up for U.S.-listed biopharmas
Tickers ALBO AMYT AZN CINC
Tags FR:IPN ALBO AMYT
From MarketWatch
Powell won’t stop rate hikes until he ‘terrifies’ the wealthiest of investors, says this CIO
Tickers AAPL AMC APE AZN
Tags UK:AZN BX:TMUBMUSD02Y UK:BRN00
From MarketWatch
AstraZeneca will buy U.S.-based CinCor for cardiorenal asset
Tickers AZN CINC
Tags AZN CINC UK:AZN
From MarketWatch
1 Stock Defying the Downturn to Buy, and 1 to Avoid
Tickers AZN BIIB ESALY
Tags AZN BIIB Market News
From Motley Fool
AstraZeneca's Current Valuation Not Reflective Of Its Strong Fundamentals, Analyst Says
Tickers AZN AZNCF
Tags Analyst Ratings Market News Initiation
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 5, 2023
Tickers ADAP ADPT ALLO ALLY
Tags CHRW Intraday Update GTBP
From Benzinga
What Does AstraZeneca's Debt Look Like?
Tickers AZN
Tags Benzinga News Market News
From Benzinga
3 Top Healthcare Stocks Defying the Bear Market
Tickers AZN TMDX VRTX
Tags VRTX AZN TMDX
From Motley Fool
Valneva Touts Additional Positive Heterologous Booster Data From COVID-19 Vaccine Study
Tickers AZN BNTX MRNA PFE
Tags COVID/19 Coronavirus Small Cap AZN
From Benzinga
Why Shares of Compugen Rose on Thursday
Tickers AZN CGEN
Tags Market News Recent Press Releases CGEN
From Motley Fool
This Favorable Sign Appears On AstraZeneca's Chart
Tickers AZN
Tags AZN Movers Markets
From Benzinga
Got $1,000? 5 Sensational Stocks to Buy to Start 2023 With a Bang
Tickers AVGO AZN IIPR NEE
Tags Market News AVGO NVAX
From Motley Fool
2 Market-Beating Stocks to Buy in 2023 and Hold Forever
Tickers AMGN AZN HZNP JNJ
Tags JNJ HZNP Market News
From Motley Fool
The Top Healthcare Stocks to Buy With $100
Tickers AZN BMY PFE
Tags AZN PFE BMY
From Motley Fool
Europe Approves AstraZeneca's Two Combo Therapies For Prostate, Bile Duct Cancer Settings
Tickers AZN AZNCF MRK
Tags Biotech Benzinga Briefs
From Benzinga
Top M&A Target: Madrigal Pharmaceuticals Could Be Next After Successful NASH Data, Analyst Says
Tickers AZN GILD LLY MDGL
Tags Market News Analyst Ratings MRK
From Benzinga
Could AstraZeneca's Asthma Drug Candidate Generate Billions?
Tickers AZN JEF
Tags JEF Recent Press Releases Market News
From Motley Fool
AstraZeneca - Daiichi Sankyo's Enhertu Wins European Approval For Gastric Cancer, CHMP Backs Other Cancer Drugs
Tickers AZN AZNCF DSKYF DSNKY
Tags DSKYF Market News Biotech
From Benzinga
AstraZeneca Drug Imfinzi Fails As Monotherapy In Metastatic Lung Cancer Setting
Tickers AZN AZNCF
Tags Eurasia Large Cap General
From Benzinga
AstraZeneca’s Forxiga gets EU approval recommendation for symptomatic chronic heart failure
Tickers AZN
Tags UK:AZN AZN
From MarketWatch
AstraZeneca’s Imfinzi plus Imjudo recommended for approval in the EU
Tickers AZN
Tags UK:AZN AZN
From MarketWatch
Guardant Health (GH) Stock Sinks on Disappointing Blood Test Results
Tickers AZN EXAS GH
Tags NASDAQ:EXAS,NASDAQ:GH,NYSE:AZN GH Today's Market
From InvestorPlace
< Previous 1 2
...
18 19 20 21 22 23 24 25 26
...
32 33 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.